Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,319 GBX | +0.01% | +1.62% | +16.17% |
02:05pm | ASTRAZENECA : Buy rating from JP Morgan | ZD |
05-13 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.17% | 240B | |
+29.35% | 682B | |
+30.71% | 586B | |
-2.99% | 364B | |
+17.75% | 327B | |
+3.96% | 285B | |
+9.93% | 209B | |
-8.38% | 203B | |
+7.68% | 165B | |
-1.02% | 161B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Ends Two Late-stage Studies of Hyperkalemia Drug Lokelma on Delayed Schedules